Does APOE ε2 lower LDL cholesterol and ε4 raise LDL cholesterol compared with ε3?

The APOE genotype is a primary genetic determinant of plasma lipid profiles, with evidence consistently showing that the ε2, ε3, and ε4 isoforms exert a hierarchical influence on cholesterol levels through their interaction with hepatic receptors.

Clinical evidence and population studies

Large-scale observational and cohort studies have robustly established that APOE alleles significantly modulate low-density lipoprotein cholesterol (LDL-C) levels across various populations, including postmenopausal women.

• Hierarchical effect: Data consistently show a trend where LDL-C levels are lowest in ε2 carriers, intermediate in ε3/ε3 homozygotes, and highest in ε4 carriers. For example, in a Spanish cohort, ε2 carriers had mean cholesterol concentrations of 5.54 mmol/L compared to 5.98 mmol/L in ε3 carriers.
• Impact in aging: In a study of 1,299 postmenopausal women, ε4 carriers exhibited significantly higher serum LDL-C concentrations than non-carriers. Longitudinal data indicate that ε4 carriers maintain higher total cholesterol trajectories from midlife into late life compared to those with the ε3 genotype.
• Global consistency: This genetic influence is observed across diverse ethnic groups, including Japanese and Brazilian cohorts, and remains a stable factor in lipid metabolism despite the independent lipid-raising effects of menopause.

Mechanistic explanations

The influence of APOE on cholesterol levels is driven by the structural variations of the apolipoprotein E protein, which serves as the primary ligand for the LDL receptor (LDLR) and the LDL receptor-related protein 1 (LRP1).

• APOE ε2 mechanism: The ε2 isoform has a markedly reduced binding affinity for the LDLR (less than 2% of the ε3 affinity). This initially leads to slower clearance of remnant particles; however, the liver responds by upregulating the density of LDL receptors on the surface of hepatocytes. This compensatory increase in receptor availability results in the more efficient removal of LDL particles from the blood, leading to lower circulating LDL-C.
• APOE ε4 mechanism: Conversely, the ε4 isoform exhibits high lipid-binding affinity, particularly for very-low-density lipoproteins (VLDL). This leads to more rapid clearance of these triglyceride-rich particles and their remnants. This increased flux of cholesterol into the liver triggers a downregulation of LDL receptors, which subsequently reduces the clearance of circulating LDL particles, causing LDL-C levels to rise.

Bottom line

The claim is strongly supported by science. The APOE ε2 allele is associated with lower LDL cholesterol, while the ε4 allele is associated with higher LDL cholesterol relative to the ε3 allele. These effects are mediated by genotype-specific changes in LDL receptor expression on the liver.